Intra-oral snoring devices may be acceptable for OTC sale -- FDA Dental Products Panel.
This article was originally published in The Tan Sheet
Executive Summary
INTRA-ORAL SNORING DEVICES OTC AVAILABILITY MAY BE ACCEPTABLE with appropriate safety and efficacy data, members of FDA's Dental Products Panel said at a Nov. 5 meeting in Bethesda, Md. Responding to FDA's request for general input on the possibility of over-the-counter sale of intra-oral devices for treatment of snoring and sleep apnea, most panel members felt OTC labeling for treatment of snoring, but not sleep apnea, might be conceivable.